• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number ESP100-19
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993); Central Regurgitation (4068)
Patient Problems Endocarditis (1834); Fatigue (1849); Fever (1858); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 03/08/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on 14 december 2022 a 19mm epic supra valve was implanted in the patient's aortic valve and a 27mm epic valve was implanted in the patient's mitral valve.It was reported on (b)(6) 2023, the patient experienced a fever and malaise due to prosthetic valve endocarditis (pve) on the 27mm epic valve.It was reported the physician attributed the pve occurred to the patient herself.On (b)(6) 2023, a decision was made to perform a double valve replacement procedure and explant the 19mm epic supra valve and the 27mm epic valve.It was then reported an 18mm non-abbott aortic valve was implanted in the patient's aortic valve and a 25mm sjm masters series heart valve w/ teflon cuff was implanted in the patient's mitral valve.The patient status was reported as stable.
 
Event Description
It was reported that on (b)(6) 2022 a 19mm epic supra valve was implanted in the patient's aortic valve and a 27mm epic valve was implanted in the patient's mitral valve.It was reported on (b)(6)2023, the patient experienced a fever and malaise due to prosthetic valve endocarditis (pve) on the 27mm epic valve.It was reported the physician attributed the pve to patient condition.On(b)(6) 2023, a decision was made to perform a double valve replacement procedure and explant the 19mm epic supra valve and the 27mm epic valve.It was then reported an 18mm non-abbott aortic valve was implanted in the patient's aortic valve and a 25mm sjm masters series heart valve w/ teflon cuff was implanted in the patient's mitral valve.The patient status was reported as stable.
 
Manufacturer Narrative
An event of endocarditis three months after a double valve replacement was completed and due to the endocarditis and regurgitation on both valves; both valves were explanted was reported.The investigation found that cusp 1 was torn.There was inflow thrombus on cusp 1 which had a microcalcification within it.No inflammation was present.Gram and silver stains were negative for organisms.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the endocarditis was due to the patient.The tear and thrombus noted on the valve could have contributed to the reported regurgitation.There is no indication of a product quality issue with regards to manufacture, design, or labeling.H6 medical device problem code: code 2993 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16704783
MDR Text Key312934516
Report Number2135147-2023-01541
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberESP100-19
Device Lot Number8561916
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age88 YR
Patient SexFemale
Patient Weight44 KG
-
-